Cerity Partners LLC Sells 26,279 Shares of Colgate-Palmolive Company $CL

Cerity Partners LLC trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 4.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 603,554 shares of the company’s stock after selling 26,279 shares during the quarter. Cerity Partners LLC owned 0.07% of Colgate-Palmolive worth $47,693,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. CBIZ Investment Advisory Services LLC grew its holdings in Colgate-Palmolive by 86.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after acquiring an additional 150 shares during the last quarter. Maseco LLP bought a new stake in Colgate-Palmolive during the 4th quarter worth approximately $27,000. Global Wealth Strategies & Associates grew its holdings in Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after acquiring an additional 300 shares during the last quarter. Grove Bank & Trust grew its holdings in Colgate-Palmolive by 182.6% during the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock worth $32,000 after acquiring an additional 263 shares during the last quarter. Finally, Camelot Portfolios LLC bought a new stake in Colgate-Palmolive during the 4th quarter worth approximately $32,000. 80.41% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on CL shares. TD Cowen reissued a “hold” rating and set a $85.00 target price on shares of Colgate-Palmolive in a report on Tuesday, March 31st. The Goldman Sachs Group restated a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Sunday, March 29th. JPMorgan Chase & Co. boosted their price target on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, May 4th. Finally, Bank of America dropped their price target on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research report on Friday, April 10th. Twelve analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $95.88.

Colgate-Palmolive Stock Performance

CL opened at $89.91 on Thursday. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. The company’s fifty day moving average price is $86.68 and its two-hundred day moving average price is $86.17. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a market cap of $71.94 billion, a price-to-earnings ratio of 34.98, a PEG ratio of 4.56 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same quarter in the prior year, the company posted $0.91 earnings per share. The business’s revenue was up 8.4% on a year-over-year basis. On average, analysts expect that Colgate-Palmolive Company will post 3.82 EPS for the current fiscal year.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.